Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran

Background: Nitric oxide (NO) has been associated with insulin resistance and type 2 diabetes (T2D). NO is synthesized enzymatically from l-arginine (l-Arg) by three NO synthase (NOS) isoforms, Neuronal NOS (nNOS or NOS1), Inducible NOS (iNOS or NOS2), and Endothelial NOS (eNOS or NOS3). The impact...

Full description

Bibliographic Details
Main Authors: Yasaman GARME, Mahdiyeh MOUDI, Ramin SARAVANI, Hamidreza GALAVI
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2018-11-01
Series:Iranian Journal of Public Health
Subjects:
Online Access:https://ijph.tums.ac.ir/index.php/ijph/article/view/15163
id doaj-4acc6c28c5004e4f95904fc499d70587
record_format Article
spelling doaj-4acc6c28c5004e4f95904fc499d705872021-01-02T15:45:08ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852251-60932018-11-014711Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern IranYasaman GARME0Mahdiyeh MOUDI1Ramin SARAVANI2Hamidreza GALAVI3Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, IranCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, IranCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran AND Dept. of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IranCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran AND Dept. of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran Background: Nitric oxide (NO) has been associated with insulin resistance and type 2 diabetes (T2D). NO is synthesized enzymatically from l-arginine (l-Arg) by three NO synthase (NOS) isoforms, Neuronal NOS (nNOS or NOS1), Inducible NOS (iNOS or NOS2), and Endothelial NOS (eNOS or NOS3). The impact of NOS2 gene polymorphism was investigated on the susceptibility of T2D in a sample of Iranian population (Southeastern of Iran). Methods: In 2015, the present case-control study was conducted on 152 T2D patients and 157 healthy control subjects (HCs) referring to Bu-ali Hospital of Zahedan, eastern Iran. Genotyping of NOS2 rs2779248T/C and rs1137933C/T variants were done using the Tetra-Amplification Refractory Mutation System Polymerase Chain Reaction (Tetra-ARMS PCR) method. Results: CT genotype of rs1137933C/T was significantly associated with increased risk of T2D (P<0.0001). The T allele of this single nucleotide polymorphism (SNP) was also strongly associated with T2D risk (P<0.0001). For rs2779248 T/C, TC genotype of this SNP decreased the risk of T2D (OR=0.25 95%CI= 0.15-0.42, P<0.0001); however, CC genotype of this SNP increased the risk of T2D (P<0.005). There was no significant association between clinical-demographic characteristics of T2D group with respect to both SNPS in dominant. Conclusion: CT genotype and C allele of NOS2 rs1137933 C/T polymorphism were associated with a higher risk of T2D, and no association was observed between T allele of NOS2 rs2779248 T/C polymorphism and T2D while TC genotype of this SNP decreased the risk of T2D in the study participants.   https://ijph.tums.ac.ir/index.php/ijph/article/view/15163Type 2 diabetes mellitusSingle nucleotide polymorphismNitric oxide synthase type IIInducible nitric oxide synthase
collection DOAJ
language English
format Article
sources DOAJ
author Yasaman GARME
Mahdiyeh MOUDI
Ramin SARAVANI
Hamidreza GALAVI
spellingShingle Yasaman GARME
Mahdiyeh MOUDI
Ramin SARAVANI
Hamidreza GALAVI
Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran
Iranian Journal of Public Health
Type 2 diabetes mellitus
Single nucleotide polymorphism
Nitric oxide synthase type II
Inducible nitric oxide synthase
author_facet Yasaman GARME
Mahdiyeh MOUDI
Ramin SARAVANI
Hamidreza GALAVI
author_sort Yasaman GARME
title Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran
title_short Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran
title_full Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran
title_fullStr Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran
title_full_unstemmed Nitric Oxide Synthase 2 Polymorphisms (rs2779248T/C and rs1137933C/T) and the Risk of Type 2 Diabetes in Zahedan, Southeastern Iran
title_sort nitric oxide synthase 2 polymorphisms (rs2779248t/c and rs1137933c/t) and the risk of type 2 diabetes in zahedan, southeastern iran
publisher Tehran University of Medical Sciences
series Iranian Journal of Public Health
issn 2251-6085
2251-6093
publishDate 2018-11-01
description Background: Nitric oxide (NO) has been associated with insulin resistance and type 2 diabetes (T2D). NO is synthesized enzymatically from l-arginine (l-Arg) by three NO synthase (NOS) isoforms, Neuronal NOS (nNOS or NOS1), Inducible NOS (iNOS or NOS2), and Endothelial NOS (eNOS or NOS3). The impact of NOS2 gene polymorphism was investigated on the susceptibility of T2D in a sample of Iranian population (Southeastern of Iran). Methods: In 2015, the present case-control study was conducted on 152 T2D patients and 157 healthy control subjects (HCs) referring to Bu-ali Hospital of Zahedan, eastern Iran. Genotyping of NOS2 rs2779248T/C and rs1137933C/T variants were done using the Tetra-Amplification Refractory Mutation System Polymerase Chain Reaction (Tetra-ARMS PCR) method. Results: CT genotype of rs1137933C/T was significantly associated with increased risk of T2D (P<0.0001). The T allele of this single nucleotide polymorphism (SNP) was also strongly associated with T2D risk (P<0.0001). For rs2779248 T/C, TC genotype of this SNP decreased the risk of T2D (OR=0.25 95%CI= 0.15-0.42, P<0.0001); however, CC genotype of this SNP increased the risk of T2D (P<0.005). There was no significant association between clinical-demographic characteristics of T2D group with respect to both SNPS in dominant. Conclusion: CT genotype and C allele of NOS2 rs1137933 C/T polymorphism were associated with a higher risk of T2D, and no association was observed between T allele of NOS2 rs2779248 T/C polymorphism and T2D while TC genotype of this SNP decreased the risk of T2D in the study participants.  
topic Type 2 diabetes mellitus
Single nucleotide polymorphism
Nitric oxide synthase type II
Inducible nitric oxide synthase
url https://ijph.tums.ac.ir/index.php/ijph/article/view/15163
work_keys_str_mv AT yasamangarme nitricoxidesynthase2polymorphismsrs2779248tcandrs1137933ctandtheriskoftype2diabetesinzahedansoutheasterniran
AT mahdiyehmoudi nitricoxidesynthase2polymorphismsrs2779248tcandrs1137933ctandtheriskoftype2diabetesinzahedansoutheasterniran
AT raminsaravani nitricoxidesynthase2polymorphismsrs2779248tcandrs1137933ctandtheriskoftype2diabetesinzahedansoutheasterniran
AT hamidrezagalavi nitricoxidesynthase2polymorphismsrs2779248tcandrs1137933ctandtheriskoftype2diabetesinzahedansoutheasterniran
_version_ 1724352480120143872